Previous Article | Next Article 
Journal of Virology, March 2001, p. 2526-2534, Vol. 75, No. 6
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.6.2526-2534.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Type D Retrovirus Gag Polyprotein Interacts with
the Cytosolic Chaperonin TRiC
Suntaek
Hong,1,2
Gyu
Choi,1
Sunyoung
Park,1
An-Sik
Chung,2
Eric
Hunter,3 and
Sung S.
Rhee1,*
Laboratory of Molecular Virology, Samsung Biomedical
Research Institute, Seoul,1 and
Department of Biological Sciences, Korea Advanced Institute
of Science and Technology, Taejon,2 Korea, and
Department of Microbiology, University of Alabama at
Birmingham, Birmingham, Alabama 352943
Received 29 August 2000/Accepted 19 December 2000
 |
ABSTRACT |
The carboxy terminus-encoding portion of the gag gene
of Mason-Pfizer monkey virus (M-PMV), the prototype immunosuppressive primate type D retrovirus, encodes a 36-amino-acid, proline-rich protein domain that, in the mature virion, becomes the p4 capsid protein. The p4 domain has no known role in M-PMV replication. We found
that two mutants with premature termination codons that remove half or
all of the p4 domain produced lower levels of stable Gag protein and of
self-assembled capsids. Interestingly, yeast two-hybrid screening
revealed that p4 specifically interacted with TCP-1
, a subunit of
the chaperonin TRiC (TCP-1 ring complex). TRiC is a cytosolic
chaperonin that is known to be involved in both folding and subunit
assembly of a variety of cellular proteins. TCP-1
also associated
with high specificity with the M-PMV pp24/16-p12 domain and human
immunodeficiency virus p6. Moreover, in cells, Gag polyprotein
associated with the TRiC chaperonin complex and this association
depended on ATP hydrolysis. In the p4 truncation mutants, the Gag-TRiC
association was significantly reduced. These results strongly suggest
that cytosolic chaperonin TRiC is involved in Gag folding and/or capsid
assembly. We propose that TRiC associates transiently with nascent
M-PMV Gag molecules to assist in their folding. Consequently, properly
folded Gag molecules carry out the intermolecular interactions involved
in self-assembly of the immature capsid.
 |
INTRODUCTION |
The infectious virus particle of the
Mason-Pfizer monkey virus (M-PMV) contains at least six capsid
proteins: p10 (MA; matrix), pp24/16, p12, p27 (CA; capsid), p14 (NC;
nucleocapsid), and p4 (3, 46). As with other retroviruses,
these capsid proteins are produced by proteolytic cleavage, during or
shortly after budding, of the gag gene-encoded precursor
polyprotein (Gag polyprotein). Gag polyproteins are synthesized in
M-PMV-infected cells along with two other Gag-related polyproteins
(Gag-Pro and Gag-Pro-Pol, encoded by the gag-pro gene and
the gag-pro-pol gene, respectively). The three
Gag-containing polyproteins are then assembled within the cytoplasm
into an immature capsid and transported to the plasma membrane, where
budding occurs. In the past two decades, extensive molecular studies of
M-PMV and other retroviruses have examined the biological roles of the
capsid proteins during retroviral infection. In addition to their roles
as processed components of mature virions, capsid proteins are critical
as constituents of the Gag precursor for the multiple events of protein
folding, transport, and assembly in the final stages of retrovirus
replication (reviewed in references 12 and 44).
The capsid proteins of MA, CA, and NC, although they show very little
conservation in amino acid sequences among different retroviruses, are
located in the same relative positions on the Gag precursor and have
some shared functions (50). However, the carboxy-terminal
domain is highly diversified. In Rous sarcoma virus (RSV), the virus
protease is found at the carboxy terminus of the Gag polyprotein
(2), whereas in murine leukemia virus no additional
protein is encoded 3' of the NC coding sequence (4). By
contrast, this region of M-PMV yields a small protein, p4. The p4
protein is composed of 36 amino acids, of which approximately 22% are
proline (46). Interestingly, a small, proline-rich
protein, p6, is also found at the equivalent position in the Gag
polyprotein of human immunodeficiency virus type 1 (HIV-1). Mutagenic
studies on this 6-kDa protein have suggested that p6 is involved in
efficient virus release (14) and in direct interaction
with regulatory protein Vpr for virion incorporation (1).
Furthermore, Parent et al. showed that, during the late stages of
budding, HIV p6 could functionally replace RSV p2b, a PPPY
motif-containing protein of Gag (33). Because there is no
primary sequence homology between these two proteins, it was speculated
that a host factor(s) might be recruited in a sequence-independent
manner through the proline-rich domain of these proteins to mediate
retroviral budding. In contrast to HIV p6, M-PMV p4 has no function
identified as yet.
To understand the biological roles of p4 in M-PMV replication, we
made two p4 truncation mutants, Mp4L17 and Mp4G1, which have a
carboxy-terminal 20-amino-acid deletion and a complete deletion of p4,
respectively. We found that the carboxy-terminal proline-rich domain of
M-PMV Gag appears to play a role in both stabilizing the molecule and
facilitating capsid assembly. Furthermore, yeast two-hybrid screening
revealed that this domain interacts with TCP-1
, a subunit of TRiC.
TRiC is a chaperonin that is involved in the folding of numerous
cellular proteins including actins and tubulins (9, 13, 25, 47,
51). TRiC also participates in the assembly of a functional
complex of the von Hippel-Lindau (VHL) tumor suppressor protein with
its partner proteins (10). Thus, our findings suggest that
the TRiC chaperonin complex assists nascent M-PMV Gag molecules to fold
into a stable structure, thereby allowing the intermolecular
interactions of capsid assembly to occur.
 |
MATERIALS AND METHODS |
DNAs.
Two M-PMV mutants, Mp4G1 and Mp4L17, with premature
termination codons within the p4 coding region were generated by
oligonucleotide-directed mutagenesis on single-stranded M13.SBGAG DNA,
which contains the 3' half of the gag gene, as previously
described (54). After mutagenesis, the mutated fragments
were recloned into M-PMV expression vector pSHRM15 (39) to
replace the wild-type fragment. The presence of the mutations was
confirmed by dideoxy sequencing of the double-stranded DNA
(45).
To construct bait plasmids for the yeast two-hybrid screen, the entire
coding sequence for each domain of various retroviral Gag polyproteins
used in this report was amplified from an infectious proviral genome by
PCR and then was inserted into LexA DNA binding domain plasmid pEG202
(Origin Technologies, Inc.). The prey plasmids were constructed by
cloning HeLa cDNAs (kindly provided by R. Finley, Wayne State
University School of Medicine) into hemagglutinin epitope-tagged B42
transcription activation domain plasmid pJG4-5.
To generate glutathione S-transferase (GST) fusion
constructs for in vitro binding assays, the DNA fragments encoding
various M-PMV Gag domains were amplified by PCR and ligated in frame
into the pGEX-5X-1 vector (Promega). The full-length cDNA of the human TCP-1
coding region was generated from a HeLa cDNA library by PCR
and then was cloned into prokaryotic expression vector pET21a (Novagen), to express T7 epitope-tagged TCP-1
in bacteria. It was
also engineered into Myc epitope-tagging vector pcDNA3.1/myc (Invitrogen) for expression in mammalian cells. All constructs were
verified by DNA sequencing.
Radiolabeling and immunoprecipitation of virus proteins.
COS-1 cells were transiently transfected with either wild-type or
mutant proviral DNAs of M-PMV (5 µg/35-mm-diameter plate) by a
modified calcium phosphate precipitation method (5). At 48 h after transfection, cells were pulse-labeled for 20 min with [3H]leucine (0.8 mCi/ml, 157 Ci/mmol; DuPont Co.) and
chased for various periods in complete growth medium (35).
Then, cells were lysed in lysis buffer A (50 mM Tris [pH 7.5], 1%
Triton X-100, 1% sodium deoxycholate, 0.15 M NaCl), and
cell-associated viral proteins were immunoprecipitated with rabbit
anti-p27 CA antiserum. Radiolabeled, extracellular virus particles were
pelleted from the culture medium of the pulse-chase-labeled cells by
centrifugation for 15 min at 80,000 rpm in a Beckman TLA 100 rotor at
4°C. The virus pellet was suspended in lysis buffer A supplemented
with 0.1% sodium dodecyl sulfate (SDS). Virion-associated viral
proteins were then immunoprecipitated with goat anti-M-PMV antiserum
(Division of Cancer Cause and Prevention, National Cancer Institute).
The immunoprecipitated viral proteins were separated with a 10%
resolving gel by SDS-polyacrylamide gel electrophoresis (SDS-PAGE).
Fractionation of Gag polyproteins.
Gag polyproteins were
fractionated into free and capsid-associated forms as previously
described (39). HOS (human osteosarcoma cells; ATCC
CRL-1543) cell lines containing integrated wild-type or mutant proviral
DNAs of M-PMV were established by transfection with proviral DNAs
linearized with Fsp 1 and subsequent selection in medium
containing 350 µg of hygromycin B (GIBCO BRL)/ml as described
previously (37). Cells were washed twice with TNE buffer
(10 mM Tris-HCl [pH 7.5], 0.15 M NaCl, 1 mM EDTA) and lysed with
Triton X-100 lysis buffer (0.25 M sucrose, 1% Triton X-100, 10 mM
Tris-HCl [pH 7.5], 0.14 M NaCl, 1 mM EDTA, 10 µg of DNase I/ml) for
1 h at room temperature. After removal of nuclei from the lysates
by centrifugation for 5 min in a microcentrifuge at 4°C, capsids were
pelleted through a 20% sucrose cushion by centrifugation at 80,000 rpm
for 15 min in a Beckman TLA 120.2 rotor at 4°C. Viral proteins in
supernatant and pellet fractions were separately immunoprecipitated
with rabbit anti-Gag antiserum, separated by SDS-PAGE, and detected by
Western blot assay with rabbit anti-Gag antibodies followed by
peroxidase-conjugated goat anti-rabbit antibodies using an enhanced
chemiluminescence detection system (ECL; Amersham). Quantitation of
bands was performed using the Gel-document system (Bio-Rad).
Yeast two-hybrid screening and in vitro binding assay.
To
identify the host cellular proteins that interact with M-PMV p4, a
LexA-based, two-hybrid screening assay was carried out according to the
manufacturer's instructions (Origin Technologies, Inc.). Briefly, bait
plasmids containing coding sequences of the p4 domain were
cotransformed with a LacZ reporter plasmid (pSH18-34) in the EGY48
strain (auxotrophic to histidine, leucine, tryptophan, and uracil). The
yeast was then transformed on a large scale with prey plasmids of a
HeLa cDNA library. Double transformants were obtained by plating on
minimal selective medium lacking histidine, uracil, and tryptophan and
further selected by growth on medium lacking leucine. The positive
colonies were cultured in yeast extract-peptone-dextrose rich medium,
and library plasmids were rescued and partially sequenced.
The in vitro binding assay was performed to determine direct
interactions between an M-PMV Gag domain and a TCP-1
subunit protein
as described previously with some modifications (41). In
brief, GST or fusions of GST proteins with various M-PMV Gag domains in
DH5
or BL21 (DE3) cells were induced with 0.5 mM
isopropyl-1-thio-
-D-galactopyranoside for 3 h and
subsequently purified by binding to glutathione-Sepharose (Amersham
Pharmacia Biotech Inc.). The Sepharose beads were then incubated with
0.3 µg of unfractionated whole lysates of BL21 cells expressing a
T7-tagged TCP-1
protein/ml for 1 h at 4°C in binding buffer
(25 mM HEPES [pH 7.4], 25 mM NaCl, 2.5 mM CaCl2, 1 mM
MgCl2, 0.1% Triton X-100, 0.1% bovine serum albumin
[BSA], 1 mM phenylmethylsulfonyl fluoride, and 1 µg of aprotinin, 1 µg of leupeptin, and 0.1 µg of pepstatin A/ml). After extensive
washing in the same binding buffer lacking BSA, beads were resuspended in SDS sample buffer and boiled for 5 min, and the bound proteins were
resolved by 10%-SDS PAGE. After electrophoresis, proteins were
transferred to nitrocellulose and incubated with alkaline phosphatase-conjugated T7 antibody (Novagen). The presence of the
expected GST or GST fusion proteins was checked by Coomassie brilliant
blue staining.
Cell fractionation and coimmunoprecipitation of TCP-1
with
M-PMV Gag polyprotein.
M-PMV Gag polyprotein associated with
chaperonin TRiC was detected by a combined experiment of cell
fractionation and coimmunoprecipitation. 293T cells were transiently
cotransfected with a proviral M-PMV DNA and a Myc-tagged
TCP-1
-expressing plasmid by using DMRIE-C reagent (GIBCO BRL). At
60 h after transfection, the cells were washed once with cold
phosphate-buffered saline (pH 7.4) and lysed on ice for 10 min in 0.5%
NP buffer (0.5% Nonidet P-40, 20 mM Tris [pH 7.4], 0.15 M NaCl, 5 mM
EDTA, 1mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, and 1 µg of aprotinin, 1 µg of leupeptin, and 0.1 µg of pepstatin
A/ml). Nuclei and cell debris were removed by centrifugation for 10 min
at 10,000 rpm in a microcentrifuge at 4°C. Postnuclear supernatants
were layered onto a prechilled continuous 5-to-40% (wt/vol) linear
sucrose gradient, which was then centrifuged for 183 min at 50,000 rpm
in a Beckman SW55Ti rotor at 4°C as described previously
(27). Fractions of 400 µl each were collected from the
bottom, and the Myc-tagged TCP-1
protein with its associated
proteins were coimmunoprecipitated with a mouse monoclonal anti-Myc
antibody (Invitrogen) and protein G-agarose (Boehringer Mannheim).
Proteins in the immune complex were separated by 8%-SDS PAGE and were
analyzed by Western blot assay with a mouse monoclonal anti-Myc
antibody, a rat monoclonal anti-TCP-1
antibody (StressGen), and a
purified rabbit anti-Gag antibody.
 |
RESULTS |
Synthesis and processing of wild-type and p4-truncated viral
proteins.
To understand the role of p4 in virus assembly and
replication, we generated two p4-truncated M-PMV mutants (Fig.
1). The first truncation mutant, Mp4G1,
was constructed to completely delete the p4-coding sequences of the
gag gene by changing the first codon of p4 from GGG
(glycine) to TAG (stop). The second truncation mutant, Mp4L17, was
created to delete the carboxy-terminal half of the p4 protein,
including proline clusters PEPP and PPP at positions 18 to 21 and 31 to
33, respectively. In this mutant, the 17th codon was changed from TTA
(leucine) to TAA (stop). Since ribosomal frameshifting for the
pro reading frame in M-PMV occurs upstream of the p4 coding
sequences (16, 46), the two-nucleotide substitutions in
Mp4G1 result in a change of codon TGG (tryptophan) to TTA (leucine) in
the pro reading frame. Thus, translation is expected to
produce gag-pro readthrough products (Gag-Pro polyprotein) with a single amino acid substitution. However, the mutation in Mp4L17,
changing from CTT (leucine) to CTA (leucine) in the pro reading frame, should bring no amino acid substitutions in the Gag-Pro
precursor.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 1.
Schematic representation of M-PMV mutants. The
arrangement of the structural proteins within the Gag polyprotein is
schematically presented (top). The partial amino acid sequences of the
M-PMV p4 proteins are shown below, using single-letter amino acid
codes. Prolines and carboxy-terminal residues are displayed, and other
residues are indicated by dashed lines. Numerals indicate residue
numbers. In Mp4L17, the 17th codon (TTA) was changed to a stop codon
(TAA). In Mp4G1, the first codon (GGG) was changed to a stop codon
(TAG). Arrowhead, cleavage site between the p14 NC protein and the p4
protein.
|
|
In order to determine whether the Gag proteins of these p4-truncated
mutants are synthesized and assembled normally into mature virions, we
performed a pulse-chase experiment (Fig.
2). COS-1 cells transiently transfected
with either wild-type or mutant proviral DNAs were pulse-labeled for 20 min with [3H]leucine and chased for 0.5, 1, and 2 h.
Both cell-associated (Fig. 2A) and released virion-associated proteins
(Fig. 2B) were analyzed. Two major Gag-related precursor proteins,
Pr78gag and Pr95gag-pro,
were efficiently synthesized by all cells during the pulse-labeling (Fig. 2A, lanes 1, 5, and 9). Truncated Gag polyproteins
(mtPr78gag) of Mp4G1 and Mp4L17 were smaller by
an amount consistent with their deletions (lanes 5 and 9). As expected,
the Gag-Pro polyproteins (Pr95gag-pro) were all
the same size, while the internal initiation products of the
gag gene (36) were smaller in accordance with
the sizes of the deletions (Fig. 2A).

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 2.
Immunoprecipitation of intracellular and extracellular
viral proteins. To examine the biosynthesis and turnover of Gag
(Pr78gag) and Gag-related precursor polyproteins
(Pr95gag-pro), wild-type and mutant M-PMV
proviral DNAs were transfected into COS-1 cells. (A) At 48 h after
transfection, cells were pulse-labeled for 20 min with
[3H]leucine (lanes 1, 5, and 9) and chased for 0.5 (lanes
2, 6, and 10), 1 (lanes 3, 7, and 11), and 2 h (lanes 4, 8, and
12). Cell-associated Gag-specific viral polyproteins were
immunoprecipitated with rabbit anti-p27 CA antibody. An internal
initiation product of the gag gene,
Pr68gag, is marked ( ). (B) Extracellular
virions were pelleted from the culture medium of pulse-labeled cells
after 0.5- (lanes 1, 4, and 7), 1- (lanes 2, 5, and 8), and 2-h (lanes
3, 6, and 9) chases and then immunoprecipitated with a goat anti-M-PMV
antibody.
|
|
Late in the budding process or shortly thereafter, the Gag protein is
proteolytically cleaved into capsid proteins (46). We
observed this processing as a decrease in the amount of
cell-associated, pulse-labeled Gag precursors during the chase period
(Fig. 2A). Simultaneously, virion-associated p27 and mature envelope
glycoprotein gp70env appeared in the culture
medium (Fig. 2B, lanes 1 to 3). Approximately half of the newly
synthesized Gag polyproteins appeared to be processed into mature
proteins and released as virions during the 2-h chase, consistent with
our previous results (38). In cells with either mutant
virus, much fewer of these two virion-associated proteins were detected
(Fig. 2B, lanes 4 to 9), even though a significant proportion of the
radiolabeled mutant Gag proteins were lost during the chase period
(Fig. 2A, lanes 5 to 8 and 9 to 12): after a 2-h chase about 55 to 60%
of the pulse-labeled Gag molecules were detected in cells. Thus, both
p4-truncated mutant Gag polyproteins were efficiently synthesized, but
were turned over (with an approximate 2-h half-life) without being efficiently released as virions into the culture medium. Since the
truncation of p4 triggered a degradation of the entire Gag polyprotein,
these results suggest that the proline-rich domain of the Gag carboxy
terminus is crucial for stabilizing the molecule.
We also determined the spread of these mutant viruses through the HeLa
cells by measuring reverse transcriptase (RT) activity in culture
fluids (38). There was a rapid increase in RT activity 6 to 12 days after infection with wild-type virus; in contrast, Mp4L17
mutant viruses showed a much slower rate of RT activity increase and
the levels remained low. In mutant Mp4G1-infected cells RT activity was
just above that detected with the uninfected cells (data not shown).
These results coincided with the impaired virion release from these
mutant virus-infected cells (Fig. 2B).
Fractionation of Gag polyprotein.
Since the newly synthesized
Gag proteins are assembled into capsids with a half-life of
approximately 45 min (37), it was of interest to determine
whether the p4-truncated Gag proteins were assembled into a capsid
prior to degradation. Completely assembled intracytoplasmic immature
capsids (ICAP) of M-PMV are stable and pelletable under mild
non-ionic-detergent conditions, while mature capsids and unassembled
capsid precursors (either at the plasma membrane or within the
cytoplasm) are soluble (36-38). Exploiting these different properties
of the capsids, we carried out a Gag protein fractionation experiment
to determine the extent of capsid formation with the mutant Gag
polyproteins. Since Gag polyproteins have been observed to form
pelletable aggregates when they were overexpressed in COS-1 cells
(36), we established HOS cell lines with low-level
expression of integrated wild-type or mutant proviral genomes.
After lysis of transfected HOS cells in Triton X-100 lysis buffer, Gag
polyproteins were fractionated by sedimentation into soluble
(free-protein) and pelleted (capsid-associated) forms (Fig.
3). Gag molecules in each fraction were
then analyzed by immunoprecipitation and immunoblotting with rabbit
anti-Gag antiserum. As observed previously (36), a
significant proportion (40 to 45% of total Gag) of cell-associated
wild-type M-PMV Gag proteins were found in the pelleted fraction. The
R55W mutant, which is defective in ICAP assembly, produced no pelleted
Gag. Interestingly, in the Mp4G1 and Mp4L17 mutant viruses,
approximately 15 to 20% of the total cell-associated Gag polyproteins
were incorporated into stable, pelletable particles within the
cytoplasm.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 3.
ICAP formation. To determine whether the p4-truncated
Gag polyproteins can be assembled into capsids, ICAPs were prepared
from lysates of HOS cells expressing wild-type M-PMV, the Mp4L17 and
Mp4G1 truncation mutants, and a negative-control R55W mutant that is
defective in ICAP assembly (36). Soluble (S) and
capsid-associated pelletable (P) Gag polyproteins were fractionated and
then immunoprecipitated with rabbit anti-Gag antiserum and visualized
by Western blot assay with rabbit anti-Gag antibodies. The amount of
Gag polyprotein in each band was quantified, and the ratios to the
total amount of Gag protein (% of total Gag) were determined.
|
|
Together with the results in Fig. 2A showing that mutant Gag proteins
were turned over, but with a much longer half-life than that for capsid
assembly, these results strongly suggested that p4-truncated Gag
molecules assemble capsids with reduced efficiency (approximately
30 to 50% of that for wild-type Gag molecules). However, it was not
clear whether these mutant Gag molecules assembled no capsids or
assembled mutant capsids that were readily disrupted under the
experimental conditions. To examine this further, we used electron
microscopy to study COS-1 cells transfected with each mutant genome. No
large intracytoplasmic accumulations of assembling or assembled capsids
were observed in the mutant virus-expressing cells (data not shown).
Collectively, these results led us to conclude that the rate-limiting
step of these mutant Gag polyproteins in the late stage of retrovirus
replication appears to be capsid assembly. Thus, this proline-rich
domain of the Gag molecule at the carboxy terminus may be required not
only to stabilize the molecules but also to facilitate the process of
capsid assembly.
Previously we have shown that Gag molecules of the P43L M-PMV mutant
could assemble capsids, even though they were very unstable and were
turned over rapidly with a half-life of 1 h (38).
More interestingly, electron-microscopic studies on thin sections of these mutant virus-infected cells revealed intracytoplasmic inclusions of partially assembled capsids with very few complete ones. In contrast, the p4-truncated Gag molecules had a longer half-life (2 h;
Fig. 2A) and they did not contain these structures. These observations
strengthened our hypothesis that the proline-rich sequences at the
carboxy terminus of the M-PMV Gag protein may play a role in
intracytoplasmic capsid assembly.
Specific interactions between p4 and the TCP-1
subunit of
chaperonin TRiC.
Proline-rich motifs and domains in many cellular
and viral proteins are thought to be involved in protein-protein and
protein-DNA interactions (7, 11, 18, 42). To determine
whether the M-PMV p4 domain interacts with specific host cellular
proteins to facilitate the capsid assembly process, we carried out
yeast two-hybrid screening against a HeLa cDNA library. Among several candidates with positive signals, the most abundant were cDNAs encoding
the human TCP-1
subunit of cytoplasmic chaperonin TRiC (TCP-1 ring complex).
To confirm the specificity of the interaction of p4 with TCP-1
, we
retransformed the prey plasmid coding for B42 fused to full-length
protein TCP-1
into yeast containing bait plasmids that express
proteins resulting from the fusion of LexA with various domains of a
retrovirus Gag polyprotein (Table 1).
Expression of LexA-Gag domain fusion proteins as well as a
hemagglutin-tagged full-length TCP-1
protein under the control of
the GAL promoter was confirmed (data not shown). The reporter assays of
leucine prototrophy and
-galactosidase activity revealed that the
interaction of TCP-1
with M-PMV p4 was specific, since no activation
of either reporter gene was detected with the LexA DNA binding domain
per se (Table 1; for Mp4G1, no p4 domain was fused to LexA because of
the termination codon substitution for the first codon in the p4 gene).
The p4 truncation mutant, Mp4L17, failed to activate reporter genes,
suggesting that p4, and particularly the proline clusters in the
carboxy-terminal half of p4, are crucial for binding the TCP-1
protein.
We also tested other retroviral proteins with this TCP-1
-expressing
prey plasmid (Table 1). Interestingly, the HIV-1 p6 protein, a
carboxy-terminal Gag domain with a high proline content similar to that
of M-PMV p4, was also found to interact with TCP-1
. In addition, the
M-PMV pp24/16-p12 construct had a strong interaction with TCP-1
protein. This region of M-PMV Gag contains both a p12 protein and a
phosphorylated pp24/16 protein with a proline-rich motif that was
identified as a late-budding domain (53). In contrast, the
other M-PMV Gag domains showed no interaction (MA and NC proteins) or a
very weak interaction (CA protein).
The interaction between p4 and TCP-1
was confirmed by in vitro
binding assays (Table 1). Partially purified p4- and truncated p4
(Mp417)-GST fusion proteins were bound to glutathione-Sepharose beads
and mixed with equal amounts of bacterial lysates containing T7-tagged TCP-1
proteins. The amount of T7-tagged TCP-1
protein bound to the beads was examined by Western blotting. The GST-p4 fusion
protein precipitated the T7-tagged TCP-1
protein, while the p4
mutant fusion protein did not. As a negative control, GST alone (Table
1; Mp4G1) did not bind the tagged TCP-1
protein. GST-M-PMV MA and
GST-M-PMV NC were included in these assays to confirm that no T7-tagged
TCP-1
was precipitated by these fusion proteins. These results
distinctly suggested that the proline-rich domain at the carboxy
terminus of the retrovirus Gag molecule interacts with the TCP-1
subunit protein of the TRiC chaperonin complex. In M-PMV Gag, there
appeared to be multiple interactions between Gag and TCP-1
, through
at least two different domains in p4 and pp24/16-p12.
The in vivo interaction of M-MPV p4 with TCP-1
.
The
association of p4 with TCP-1
was further examined in cells. A
coimmunoprecipitation experiment was carried out with 293T cells
transiently cotransfected with wild-type or p4-truncated proviral DNAs
and a Myc-tagged TCP-1
-expressing plasmid. Precipitation with an
anti-Myc antibody brought down wild-type Gag polyprotein Pr78gag bound to TCP-1
(Fig.
4A). The internal initiation product of Gag, Pr68gag (as shown in Fig. 2A) can also be
seen (Fig. 4A). As a negative control, no Gag was found in the immune
precipitates of antibody and protein G-agarose when cells were
transfected only with M-PMV DNAs (data not shown). These results
clearly demonstrated that M-PMV Gag polyproteins interact with TCP-1
in cells.

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 4.
Coimmunoprecipitation of wild-type and p4-truncated Gag
polyproteins with the TCP-1 subunit. (A) The cellular interactions
between M-PMV Gag polyprotein and TCP-1 protein were examined by a
coimmunoprecipitation (CO-IP) experiment. 293T cells transiently
cotransfected with wild-type or p4 mutant (Mp4L17 or Mp4G1) proviral
DNA and Myc-tagged TCP-1 -expressing plasmid DNA were lysed in 1%
NP-40-containing TNE buffer. TCP-1 -Myc and its associated proteins
were coimmunoprecipitated with mouse monoclonal anti-Myc antibody for
2 h at 4°C and then separated by 8%-SDS PAGE.
TCP-1 -Myc-bound Gag polyproteins were detected by Western blot assay
with rabbit anti-Gag antibody. Dots, internal initiation products
(Pr68gag). (B) To measure the total amount of
Gag polyprotein in each sample, equal numbers of cotransfected 293T
cells were lysed in lysis buffer A supplemented with 0.1% SDS and
total Gag polyproteins were immunoprecipitated (IP) with rabbit
anti-Gag antibody. Gag polyproteins were detected by Western blot assay
with the same antibody. (C) The amount of Gag polyprotein in each band
of panel A was quantified. The amount of TCP-1 -Myc-bound Gag
protein was normalized by that of total Gag (B) and then plotted as a
percentage. The amount bound by wild-type (wt) M-PMV is arbitrarily
presented as 100%. The data are the means and standard errors from
three separate experiments.
|
|
In contrast, much less Gag was coprecipitated with TCP-1
for mutants
Mp4L17 and Mp4G1 (Fig. 4A). We also used an anti-Gag antibody to
precipitate these lysates to verify that total Gag expression with
these mutants was similar to or higher than that with wild-type virus
(Fig. 4B). After normalizing for total Gag protein, we quantified the
Gag association with TCP-1
from Fig. 4A. The Mp4L17 and Mp4G1
mutants had approximately 40 and 60% less Gag association with
TCP-1
, respectively, than wild-type M-PMV (Fig. 4C). Comparable
amounts of Myc-tagged TCP-1
protein were detected in all immune
complexes when the same membrane was reprobed with the anti-Myc
antibody (data not shown). These results agree with those obtained from
the yeast two-hybrid system and in vitro binding assays presented in
Table 1: p4 and pp24/p16-p12 proteins in M-PMV Gag are able to
associate with the TCP-1
subunit protein of chaperonin TRiC. The
interaction of p4-truncated mutant Gag with TCP-1
was of lower
affinity and appeared to be mediated through other domain(s), yet to be
identified, including one in the pp24/p16 and p12 proteins.
Association of M-PMV Gag polyprotein with the TRiC cytoplasmic
chaperonin complex.
Having shown that the M-PMV Gag polyprotein
interacts with TCP-1
, we wanted to find whether Gag is associated
with the whole TRiC chaperonin complex, not just with free TCP-1
subunits. 293T cells were transiently cotransfected with M-PMV proviral
DNA pSHRM15 and a Myc-tagged TCP-1
-expressing plasmid. The intact
TRiC chaperonin complex has a relative molecular mass of 800 to 950 kDa
and is composed of eight different but homologous subunits (22,
24, 26). When we performed a 5-to-40% (wt/vol) sucrose
gradient, anti-TCP-1
detected the TRiC complex at 19 to 23% sucrose
(fractions 6 to 8), equivalent to a density of 1.076 to 1.094 g/ml
(Fig. 5A). This result is consistent with
densities previously observed (22, 27). Specific
antibodies against Gag and Myc-tagged TCP-1
detected proteins at two
distinct regions of the gradient, fractions 6 to 8 and 11 to 13 (Fig.
5A). In addition, Gag could be seen in fractions 1 and 2 with a higher
density, which appears to reflect assembled capsids normally recovered
from the bottom of the gradient, with a density of 1.20 g/ml (23,
43). Proteins in the later fractions (11 to 13), being at the
top of the gradient, were expected to be free molecules.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 5.
Coimmunoprecipitation of M-PMV Gag polyprotein with the
chaperonin TRiC. Cell fractionation and coimmunoprecipitation were
carried out with 293T cells transiently cotransfected with M-PMV
proviral DNA pSHRM15 and a Myc-tagged TCP-1 -expressing plasmid. (A)
The cells were lysed in 0.5% NP buffer and then fractionated through a
continuous 5-to-40% (wt/vol) linear sucrose gradient. The fractions
were collected from bottom to top and measured for sucrose density
(top) Aliquots of each fraction were analyzed by Western blot assay
with rat monoclonal anti-TCP-1 (TCP-1 ), mouse monoclonal anti-Myc
(TCP-1 -Myc), and rabbit anti-Gag (Pr78gag).
The densities of fractions 6 and 7 (1.076 and 1.086 g/ml, respectively)
are near the expected density of the TRiC complex. (B) Peaks I and II
(pooled fractions 6 and 7 and 11 and 12, respectively) were diluted
with 0.5% NP buffer and then used to coimmunoprecipitate TCP-1 -Myc
and its associated proteins with a mouse monoclonal anti-Myc antibody.
Proteins in the immune complex were analyzed as described above for
TCP-1 -Myc, TCP-1 , and Gag by Western blot assay.
|
|
For further analysis, we pooled fractions 6 and 7 (peak I; density of
1.076 to 1.086 g/ml) and fractions 11 and 12 (peak II). These fractions
were then used to coimmunoprecipitate TCP-1
-Myc as well as its
associated proteins. A Myc-specific monoclonal antibody precipitated
endogenous TCP-1
, TCP-1
, and Gag from fractions 6 and 7 (Fig. 5B,
lane I). By contrast, neither Gag nor TCP-1
was detected in
fractions 11 and 12, even though substantial amounts of TCP-1
were
precipitated (Fig. 5B, lane II). These results clearly demonstrated
that M-PMV Gag polyproteins associate with cytoplasmic chaperonin TRiC
in virus-infected cells, presumably through the TCP-1
subunit.
It is noteworthy that significant steady-state levels of Myc-tagged
TCP-1
were found with the complex, suggesting that the exogenous,
overexpressed TCP-1
molecules were folded correctly and complexed
with other subunits of TRiC. Furthermore, we found that
TCP-1
-specific antibodies coimmunoprecipitated both Gag and
TCP-1
, along with TCP-1
, from fractions 6 and 7 (data not shown).
Thus, these findings raised the possibilities that the interaction with
TRiC allows nascent Gag molecules to be properly folded into a native
structure and/or assembled into a capsid.
ATP requirement for M-PMV Gag release from TRiC.
TRiC, like
other chaperones, assists in protein folding by ATP-dependent cycles of
release and rebinding (13, 17, 28, 31). Indeed,
substrates, such as tubulin, actin, and firefly luciferase, are
released from the substrate-TRiC complex upon incubation with ATP, but
not with nonhydrolyzable analogues (13, 31, 52). Since the
data described above suggested that TRiC mediates M-PMV Gag folding
and/or assembly, we investigated whether Gag proteins dissociate from
TRiC in an ATP-dependent fashion.
Aliquots of 293T cell lysates expressing M-PMV viral and TCP-1
-Myc
proteins were treated with 0.04, 0.4, and 4 mM ATP on ice for 1 h
in the presence of 2 mM MgCl2 prior to
coimmunoprecipitation with a Myc-specific antibody. In the presence of
ATP, even as little as 0.04 mM, much less Gag associated with TCP-1
(Fig. 6A). In addition, the effect of ATP
activity on Gag release was concentration dependent with nearly maximal
release around 0.1 to 0.4 mM. These observations were confirmed by
competition assays with nonnonhydrolyzable ATP analog ATP-
-S (Fig.
6B). When increasing amounts of ATP-
-S were added to the reaction
mixture with 0.1 mM ATP, release was inhibited in a
concentration-dependent manner, while there were no changes in the
amount of TCP-1
associated with the complex (Fig. 6B). Therefore, we
can conclude that M-PMV Gag, like other TRiC-associated proteins,
depends on ATP hydrolysis for its release from the chaperone.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 6.
Effects of ATP and ATP- -S on the M-PMV Gag
association with the chaperonin TRiC. 293T cells transiently
cotransfected with an M-PMV proviral DNA and a TCP-1 -Myc-expressing
plasmid were lysed in 1% NP-40-containing TNE buffer. (A) Cell lysates
were incubated with 2 mM MgCl2 and various concentrations
of ATP on ice for 1 h prior to coimmunoprecipitation with mouse
monoclonal anti-Myc antibody. TCP-1 -Myc and Gag proteins were
detected by Western blot assay with mouse anti-Myc and rabbit anti-Gag
antibodies, respectively. The sample with no ATP was sham treated with
H2O. (B) To confirm the effect of ATP on dissociation of
Gag proteins from TRiC, competition assays were carried out with
nonhydrolyzable ATP analog ATP- -S. Cell lysates were treated for 1 h
on ice with various concentrations of ATP- -S in the presence of 0.1 mM ATP and 2 mM MgCl2. After coimmunoprecipitation with an
anti-Myc antibody, TCP-1 -Myc, TCP-1 , and Gag proteins were
detected as described above with mouse anti-Myc, rat anti-TCP-1 , and
rabbit anti-Gag antibodies, respectively.
|
|
 |
DISCUSSION |
In cells, newly synthesized proteins fold into a native structure,
a state of minimum potential energy, by poorly defined mechanisms, in
which molecular chaperones play a fundamental role (8, 15,
21). In addition, molecular chaperones are believed to assist in
intracellular targeting and complex assembly of folded native proteins
(29). Two major families of molecular chaperones, the
70-kDa heat shock protein cognate (Hsc70) and the chaperonin TCP-1 ring
complex (TRiC), mediate such functions in the eukaryotic cell cytosol.
Hsc70 appears to be predominant, interacting with the majority of
cytosolic nascent polypeptides over 20 kDa, whereas TRiC has been found
to interact with a small subset of newly synthesized proteins of 30 and
60 kDa, about 9 to 15% of all cytosolic proteins (49). To
date, only a few proteins have been identified as TRiC folding
substrates, including actin, tubulin (13), G
-transducin (9), myosin II (47), and the VHL tumor
suppressor protein (10). Here we describe the
ATP-dependent interaction of the gag gene product of type D
retroviruses with cytosolic chaperonin TRiC, with the likelihood that
the Gag polyprotein is a TRiC folding substrate.
This study shows that the carboxy-terminal proline-rich protein, p4, of
M-PMV Gag polyprotein interacts specifically in vitro and in vivo with
TCP-1
, a subunit of TRiC, thereby mediating the interaction between
Gag polyprotein and TRiC (Table 1 and Fig. 4). When the p4 domain was
partially or completely deleted through premature termination
mutations, the interaction between the p4-truncated Gag and TCP-1
was impaired: there was a 40 to 60% drop in the amount of
TCP-1
-associated mutant Gag compared to that with wild-type Gag
(Fig. 4). The pp24/16-p12 domain on Gag was also identified in vitro as
an additional TCP-1
binding site, suggesting that multiple bindings
of M-PMV Gag to TRiC may be required for stable interaction between the
two molecules. Of note, capsid assembly by these mutants occurred at
similarly reduced kinetics: immature capsids were assembled in the
cytoplasm inefficiently, with a 50 to 70% drop in the relative ratio
of particle-associated Gag to total Gag (Fig. 3). Together, these data
suggest that the M-PMV Gag-associated TRiC chaperonin complex probably
promotes the process of capsid assembly.
Retroviral capsid assembly requires a series of events including
synthesis and modification of the Gag polyprotein, folding into a
stable conformation, transport to the site of assembly, and
multimerization to form a complex of 2,000 to 3,000 molecules. These
processes depend on host cell proteins and machinery. In particular,
the folding of Gag to an assembly-competent form is critical in the
late phase of the retrovirus life cycle, capsid assembly being
dependent on the intermolecular interactions between Gag molecules. Our
previous studies of M-PMV mutants with in-frame deletions
(37) or proline-to-leucine substitution mutations (38) within MA agree well with this notion. Mutant Gag
molecules appeared to be folded into an unfavorable conformation,
exhibiting rapid turnover with a half-life of less than 1 h. The
unfavorable conformation interfered with the assembly process such that
very few capsids were completed. It should be noted that these
characteristics of stability-assembly-defective mutants differ from
those seen with assembly-defective ones with single-amino-acid
substitutions in the major homology region of M-PMC CA
(48). Typically, the latter mutants express stable Gag
molecules with a half-life of 4 h but with no visibly assembled or
assembling capsids, suggesting that these mutant Gag proteins fold into
a favorable ternary conformation but without the ability to assemble a
capsid. Consequently, no virus particles are released. Interestingly,
the phenotype observed with the p4-truncated mutants we present here is
somewhat different from both defective phenotypes. The p4-truncated Gag
molecules were turned over with intermediate kinetics (half-life of
2 h; Fig. 2 A) and assembled into capsids with a 50%-reduced
efficiency compared to that of the wild type (Fig. 3); those that were
assembled were able to be transported to the plasma membrane and
released (Fig. 2B). Thus, p4, most likely through the TRiC interaction, appears to play a critical role in the processes whereby Gag acquires stable conformations and assembly competency. We argue that TRiC assists type D retrovirus Gag folding into a native structure, which
confers stability on the molecule. The impaired interaction with TRiC
may render intermediate stability to the p4 mutant Gag, which was then
subject to degradation mechanisms, resulting in inefficient capsid assembly.
Feldman et al. (10) demonstrated that, in addition to a
role in chaperoning monomeric protein folding, TRiC assists in the assembly of a functional VBC complex by mediating incorporation of
tumor suppressor protein VHL into a complex with its partner proteins,
elongin B and elongin C. Such involvement in protein multimerization
was also implicated in assembly of hepatitis B virus capsid by showing
that TRiC or a related chaperonin associates with assembly
intermediates but not with either the initial unassembled virus core
proteins or the mature capsid (29). Thus, it remains possible that TRiC mediates capsid assembly as well as Gag folding in
M-PMV. The reduced capsid assembly observed with the p4 truncation mutants might reflect a mere defect in this additional role of TRiC.
Although this is a formal possibility, we favor the interpretation that
TRiC assists in Gag folding, not assembly, because we have shown that
the purified recombinant M-PMV Gag molecules can assemble capsid-like
structures in vitro (23).
The p4 domain of M-PMV Gag is proline rich, with the proline residues
clustered at the carboxy half of the domain. This proline-rich domain
appears to be necessary for Gag interaction with TCP-1
. In many
proteins, cellular and viral proline-rich motifs have been shown to be
involved in multiprotein interactions, as was found in the
vesicle-associated proteins and the SH3 domain binding proteins.
Mutational studies on various retroviral Gag polyproteins have also
suggested that conserved proline-rich motifs serve as docking sites for
the cellular protein(s) to mediate the budding process (14, 19,
33, 34, 53). In addition, HIV-1 Gag association with molecular
chaperone cyclophilin A (11) is mediated by a proline-rich
segment within CA. More interestingly, HIV-1 p6, analogous to M-PMV p4,
exhibits a strong interaction with TCP-1
in the yeast two-hybrid
system (Table 1). However, no sequence homology between the p4 and p6
proteins can be seen except for their unusually high proline content.
The core TRiC binding domain of
-tubulin was defined through
mutagenesis and proteolytic analyses; it spans amino acids 150 to 350 and contains many proline and hydrophobic residues (6,
40). There are no conserved sequences among the core domains of
-tubulin, VHL (10), and
-actin (20).
Thus, our data support the speculation that TRiC may interact with its
folding substrates in a sequence-independent manner through structural
motifs contributed by proline residues.
In summary, the data presented here suggest a mechanism by which the
gag gene products of a type D retrovirus acquire an
assembly-competent folded conformation. Although the details of the
mechanism involved in this folding process have yet to be investigated,
our findings imply that the TRiC chaperonin complex assists in the
folding of newly synthesized Gag polyproteins to a native structure.
The TRiC-Gag interaction can be achieved through the association
between the p4 and pp24/16-p12 domains of Gag and the TRiC subunit
protein, TCP-1
. This interaction is transient, with release of Gag
from the chaperonin complex in an ATP hydrolysis-dependent reaction, as
seen in TRiC-mediated folding of firefly luciferase and tubulin (13, 32). Insufficient interaction between these
molecules, shown with the p4-truncated mutants, appears to impair the
TRiC folding process, which likely results in incorrect folding
reactions that induce Gag protein degradation. Consequently, capsid
assembly and virus release are inefficient. Many molecular chaperones, such as cyclophilin A, hsp27, hsp70, and hsp78, have been shown to
interact with HIV Gag (11). It seems likely, then, that
several cellular chaperones function in tandem to promote productive
folding of retroviral Gag to a native form.
 |
ACKNOWLEDGMENTS |
We thank R. Finley for the HeLa cDNA library. We are grateful to
members of our laboratory for discussion during the project and to J. Macke for substantive editing of the manuscript.
This work was supported by grant B-98015 to S.S.R. from the Samsung
Biomedical Research Institute and by grant R39 CA27834 to E.H. from the
National Cancer Institute.
 |
FOOTNOTES |
*
Corresponding author. Present address: Laboratory of
Molecular Biology, NIMH, Building 36, Room 1D03, MSC 4034, Bethesda, MD
20892. Phone: (301) 402-1040. Fax: (301) 402-0245. E-mail: ssrhee{at}netscape.net.
 |
REFERENCES |
| 1.
|
Bachand, F.,
X. J. Yao,
M. Hrimech,
N. Rougeau, and É. A. Cohen.
1999.
Incorporation of Vpr into human immunodeficiency virus type 1 requires a direct interaction with the p6 domain of the p55 Gag precursor.
J. Biol. Chem.
274:9083-9091[Abstract/Free Full Text].
|
| 2.
|
Bennett, R. P.,
S. Rhee,
R. C. Craven,
E. Hunter, and J. W. Wills.
1991.
Amino acids encoded downstream of gag are not required by Rous sarcoma virus protease during Gag-mediated assembly.
J. Virol.
65:272-280[Abstract/Free Full Text].
|
| 3.
|
Bradac, J., and E. Hunter.
1984.
Polypeptides of Mason-Pfizer monkey virus. I. Synthesis and processing of the gag-gene products.
Virology
138:260-275[CrossRef][Medline].
|
| 4.
|
Chattopadhyay, S. K.,
D. N. Sengupta,
T. N. Fredrickson,
H. C. Morse, and J. W. Hartley.
1991.
Characteristics and contributions of defective, ecotropic, and mink cell focus-inducing viruses involved in a retrovirus-induced immunodeficiency syndrome of mice.
J. Virol.
65:4232-4241[Abstract/Free Full Text].
|
| 5.
|
Chen, C., and H. Okayama.
1987.
High-efficiency transformation of mammalian cells by plasmid DNA.
Mol. Cell. Biol.
7:2745-2752[Abstract/Free Full Text].
|
| 6.
|
Dobrzynski, J. K.,
M. L. Sternlicht,
G. W. Farr, and H. Sternlicht.
1996.
Newly-synthesized -tubulin demonstrates domain-specific interactions with the cytosolic chaperonin.
Biochemistry
35:15870-15882[CrossRef][Medline].
|
| 7.
|
Drees, B.,
E. Friederich,
J. Fradelizi,
D. Louvard,
M. C. Beckerle, and R. M. Golsteyn.
2000.
Characterization of the interaction between zyxin and members of the Ena/vasodilator-stimulated phosphoprotein family of proteins.
J. Biol. Chem.
275:22503-22511[Abstract/Free Full Text].
|
| 8.
|
Ellis, J.
1987.
Proteins as molecular chaperones.
Nature
328:378-379[CrossRef][Medline].
|
| 9.
|
Farr, G. W.,
E. C. Scharl,
R. J. Schumacher,
S. Sondek, and A. L. Horwich.
1997.
Chaperonin-mediated folding in the eukaryotic cytosol proceeds through rounds of release of native and nonnative forms.
Cell
89:927-937[CrossRef][Medline].
|
| 10.
|
Feldman, D. E.,
V. Thulasiraman,
R. G. Ferreyra, and J. Frydman.
1999.
Formation of the VHL-elongin BC tumor suppressor complex is mediated by the chaperonin TRiC.
Mol. Cell
4:1051-1061[CrossRef][Medline].
|
| 11.
|
Franke, E. K.,
H. E. Yuan, and J. Luban.
1994.
Specific incorporation of cyclophilin A into HIV-1 virions.
Nature
372:359-362[CrossRef][Medline].
|
| 12.
|
Freed, E. O.
1998.
HIV-1 Gag proteins: diverse functions in the virus life cycle.
Virology
251:1-15[CrossRef][Medline].
|
| 13.
|
Frydman, J.,
E. Nimmesgern,
H. Erdjument-Bromage,
J. S. Wall,
P. Tempst, and F. U. Hartl.
1992.
Function in protein folding of TRiC, a cytosolic ring complex containing TCP-1 and structurally related subunits.
EMBO J.
11:4767-4778[Medline].
|
| 14.
|
Göttlinger, H. G.,
T. Dorfman,
J. G. Sodroski, and W. A. Haseltine.
1991.
Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release.
Proc. Natl. Acad. Sci. USA
88:3195-3199[Abstract/Free Full Text].
|
| 15.
|
Hartl, F. U.
1996.
Molecular chaperones in cellular protein folding.
Nature
381:571-579[CrossRef][Medline].
|
| 16.
|
Hatfield, D. L.,
J. G. Levin,
A. Rein, and S. Oroszlan.
1992.
Translational suppression in retroviral gene expression.
Adv. Virus Res.
41:193-239[Medline].
|
| 17.
|
Hendrick, J. P., and F. U. Hartl.
1995.
The role of molecular chaperones in protein folding.
FASEB J.
9:1559-1569[Abstract].
|
| 18.
|
Houchens, C. R.,
W. Montigny,
L. Zeltser,
L. Dailey,
J. M. Gilbert, and N. H. Heintz.
2000.
The dhfr ori -binding protein RIP60 contains 15 zinc fingers: DNA binding and looping by the central three fingers and an associated proline-rich region.
Nucleic Acids Res.
28:570-581[Abstract/Free Full Text].
|
| 19.
|
Huang, M.,
J. M. Orenstein,
M. A. Martin, and E. O. Freed.
1995.
p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease.
J. Virol.
69:6810-6818[Abstract].
|
| 20.
|
Hynes, G. M., and K. R. Willison.
2000.
Individual subunits of the eukaryotic cytosolic chaperonin mediate interactions with binding sites located on subdomains of -actin.
J. Biol. Chem.
275:18985-18994[Abstract/Free Full Text].
|
| 21.
|
Johnson, J. L., and E. A. Craig.
1997.
Protein folding in vivo: unraveling complex pathways.
Cell
90:201-204[CrossRef][Medline].
|
| 22.
|
Joly, E. C.,
E. Tremblay,
R. M. Tanguay,
Y. Wu, and V. Bibor-Hardy.
1994.
TRiC-P5, a novel TCP1-related protein, is localized in the cytoplasm and in the nuclear matrix.
J. Cell Sci.
107:2851-2859[Abstract].
|
| 23.
|
Klikova, M.,
S. S. Rhee,
E. Hunter, and T. Ruml.
1995.
Efficient in vivo and in vitro assembly of retroviral capsids from Gag precursor proteins expressed in bacteria.
J. Virol.
69:1093-1098[Abstract].
|
| 24.
|
Kubota, H.,
G. Hynes, and K. Willison.
1995.
The chaperonin containing t-complex polypeptide 1 (TCP-1). Multisubunit machinery assisting in protein folding and assembly in the eukaryotic cytosol.
Eur. J. Biochem.
230:3-16[Medline].
|
| 25.
|
Leroux, M. R., and F. U. Hartl.
2000.
Protein folding: versatility of the cytosolic chaperonin TRiC/CCT.
Curr. Biol.
10:R260-R264[CrossRef][Medline].
|
| 26.
|
Lewis, S. A.,
G. Tian,
I. E. Vainberg, and N. J. Cowan.
1996.
Chaperonin-mediated folding of actin and tubulin.
J. Cell Biol.
132:1-4[Free Full Text].
|
| 27.
|
Lewis, V. A.,
G. M. Hynes,
D. Zheng,
H. Saibil, and K. Willison.
1992.
T-complex polypeptide-1 is a subunit of a heteromeric particle in the eukaryotic cytosol.
Nature
358:249-252[CrossRef][Medline].
|
| 28.
|
Li, W. Z.,
P. Lin,
J. Frydman,
T. R. Boal,
T. S. Cardillo,
L. M. Richard,
D. Toth,
M. A. Lichtman,
F. U. Hartl, and F. Sherman.
1994.
Tcp20, a subunit of the eukaryotic TRiC chaperonin from humans and yeast.
J. Biol. Chem.
269:18616-18622[Abstract/Free Full Text].
|
| 29.
|
Lingappa, J. R.,
R. L. Martin,
M. L. Wong,
D. Ganem,
W. J. Welch, and V. R. Lingappa.
1994.
A eukaryotic cytosolic chaperonin is associated with a high molecular weight intermediate in the assembly of hepatitis B virus capsid, a multimeric particle.
J. Cell Biol.
125:99-111[Abstract/Free Full Text].
|
| 30.
|
Liu, C., and M. J. Welsh.
1999.
Identification of a site of Hsp27 binding with Hsp27 and B-crystallin as indicated by the yeast two-hybrid system.
Biochem. Biophys. Res. Commun.
255:256-261[CrossRef][Medline].
|
| 31.
|
Marco, S.,
J. L. Carrascosa, and J. M. Valpuesta.
1994.
Reversible interaction of -actin along the channel of the TCP-1 cytoplasmic chaperonin.
Biophys. J.
67:364-368[Abstract/Free Full Text].
|
| 32.
|
Nimmesgern, E., and F. U. Hartl.
1993.
ATP-dependent protein refolding activity in reticulocyte lysate. Evidence for the participation of different chaperone components.
FEBS Lett.
331:25-30[CrossRef][Medline].
|
| 33.
|
Parent, L. J.,
R. P. Bennett,
R. C. Craven,
T. D. Nelle,
N. K. Krishna,
J. B. Bowzard,
C. B. Wilson,
B. A. Puffer,
R. C. Montelaro, and J. W. Wills.
1995.
Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins.
J. Virol.
69:5455-5460[Abstract].
|
| 34.
|
Puffer, B. A.,
L. J. Parent,
J. W. Wills, and R. C. Montelaro.
1997.
Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein.
J. Virol.
71:6541-6546[Abstract].
|
| 35.
|
Rhee, S. S., and E. Hunter.
1987.
Myristylation is required for intracellular transport but not for assembly of D-type retrovirus capsids.
J. Virol.
61:1045-1053[Abstract/Free Full Text].
|
| 36.
|
Rhee, S. S., and E. Hunter.
1990.
A single amino acid substitution within the matrix protein of a type D retrovirus converts its morphogenesis to that of a type C retrovirus.
Cell
63:77-86[CrossRef][Medline].
|
| 37.
|
Rhee, S. S., and E. Hunter.
1990.
Structural role of the matrix protein of type D retroviruses in Gag polyprotein stability and capsid assembly.
J. Virol.
64:4383-4389[Abstract/Free Full Text].
|
| 38.
|
Rhee, S. S., and E. Hunter.
1991.
Amino acid substitutions within the matrix protein of type D retroviruses affect assembly, transport and membrane association of a capsid.
EMBO J.
10:535-546[Medline].
|
| 39.
|
Rhee, S. S.,
H. X. Hui, and E. Hunter.
1990.
Preassembled capsids of type D retroviruses contain a signal sufficient for targeting specifically to the plasma membrane.
J. Virol.
64:3844-3852[Abstract/Free Full Text].
|
| 40.
|
Rommelaere, H.,
M. De Neve,
R. Melki,
J. Vandekerckhove, and C. Ampe.
1999.
The cytosolic class II chaperonin CCT recognizes delineated hydrophobic sequences in its target proteins.
Biochemistry
38:3246-3257[CrossRef][Medline].
|
| 41.
|
Rossi, F.,
A. Evstafieva,
G. Pedrali-Noy,
A. Gallina, and G. Milanesi.
1997.
HsN3 proteasomal subunit as a target for human immunodeficiency virus type 1 Nef protein.
Virology
237:33-45[CrossRef][Medline].
|
| 42.
|
Roth, J.,
P. Koch,
A. Contente, and M. Dobbelstein.
2000.
Tumor-derived mutations within the DNA-binding domain of p53 that phenotypically resemble the deletion of the proline-rich domain.
Oncogene
19:1834-1842[CrossRef][Medline].
|
| 43.
|
Sakalian, M.,
S. D. Parker,
R. A. Weldon, Jr., and E. Hunter.
1996.
Synthesis and assembly of retrovirus Gag precursors into immature capsids in vitro.
J. Virol.
70:3706-3715[Abstract].
|
| 44.
|
Sakalian, M., and E. Hunter.
1998.
Molecular events in the assembly of retrovirus particles.
Adv. Exp. Med. Biol.
440:329-339[Medline].
|
| 45.
|
Sanger, F.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain-terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467[Abstract/Free Full Text].
|
| 46.
|
Sonigo, P.,
C. Barker,
E. Hunter, and S. Wain-Hobson.
1986.
Nucleotide sequence of Mason-Pfizer monkey virus: an immunosuppressive D-type retrovirus.
Cell
45:375-385[CrossRef][Medline].
|
| 47.
|
Srikakulam, R., and D. A. Winkelmann.
1999.
Myosin II folding is mediated by a molecular chaperonin.
J. Biol. Chem.
274:27265-27273[Abstract/Free Full Text].
|
| 48.
|
Strambio-de-Castillia, C., and E. Hunter.
1992.
Mutational analysis of the major homology region of Mason-Pfizer monkey virus by use of saturation mutagenesis.
J. Virol.
66:7021-7032[Abstract/Free Full Text].
|
| 49.
|
Thulasiraman, V.,
C. F. Yang, and J. Frydman.
1999.
In vivo newly translated polypeptides are sequestered in a protected folding environment.
EMBO J.
18:85-95[CrossRef][Medline].
|
| 50.
|
Wills, J. W., and R. C. Craven.
1991.
Form, function, and use of retroviral Gag proteins.
AIDS
5:639-654[Medline].
|
| 51.
|
Won, K. A.,
R. J. Schumacher,
G. W. Farr,
A. L. Horwich, and S. I. Reed.
1998.
Maturation of human cyclin E requires the function of eukaryotic chaperonin CCT.
Mol. Cell. Biol.
18:7584-7589[Abstract/Free Full Text].
|
| 52.
|
Yaffe, M. B.,
G. W. Farr,
D. Miklos,
A. L. Horwich,
M. L. Sternlicht, and H. Sternlicht.
1992.
TCP1 complex is a molecular chaperone in tubulin biogenesis.
Nature
358:245-248[CrossRef][Medline].
|
| 53.
|
Yasuda, J., and E. Hunter.
1998.
A proline-rich motif (PPPY) in the Gag polyprotein of Mason-Pfizer monkey virus plays a maturation-independent role in virion release.
J. Virol.
72:4095-4103[Abstract/Free Full Text].
|
| 54.
|
Zoller, M. J., and M. Smith.
1984.
Oligonucleotide-directed mutagenesis: a simple method using two oligonucleotide primers and a single-stranded DNA template.
DNA
3:479-488[Medline].
|
Journal of Virology, March 2001, p. 2526-2534, Vol. 75, No. 6
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.6.2526-2534.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Life, R. B., Lee, E.-G., Eastman, S. W., Linial, M. L.
(2008). Mutations in the Amino Terminus of Foamy Virus Gag Disrupt Morphology and Infectivity but Do Not Target Assembly. J. Virol.
82: 6109-6119
[Abstract]
[Full Text]
-
Jin, J., Sturgeon, T., Chen, C., Watkins, S. C., Weisz, O. A., Montelaro, R. C.
(2007). Distinct Intracellular Trafficking of Equine Infectious Anemia Virus and Human Immunodeficiency Virus Type 1 Gag during Viral Assembly and Budding Revealed by Bimolecular Fluorescence Complementation Assays. J. Virol.
81: 11226-11235
[Abstract]
[Full Text]
-
Geller, R., Vignuzzi, M., Andino, R., Frydman, J.
(2007). Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance. Genes Dev.
21: 195-205
[Abstract]
[Full Text]
-
BELIAKOVA-BETHELL, N., BECKHAM, C., GIDDINGS, T. H. JR, WINEY, M., PARKER, R., SANDMEYER, S.
(2006). Virus-like particles of the Ty3 retrotransposon assemble in association with P-body components. RNA
12: 94-101
[Abstract]
[Full Text]
-
Song, C., Micoli, K., Bauerova, H., Pichova, I., Hunter, E.
(2005). Amino Acid Residues in the Cytoplasmic Domain of the Mason-Pfizer Monkey Virus Glycoprotein Critical for Its Incorporation into Virions. J. Virol.
79: 11559-11568
[Abstract]
[Full Text]
-
Irwin, B., Aye, M., Baldi, P., Beliakova-Bethell, N., Cheng, H., Dou, Y., Liou, W., Sandmeyer, S.
(2005). Retroviruses and yeast retrotransposons use overlapping sets of host genes. Genome Res
15: 641-654
[Abstract]
[Full Text]
-
Morikawa, Y., Goto, T., Momose, F.
(2004). Human Immunodeficiency Virus Type 1 Gag Assembly through Assembly Intermediates. J. Biol. Chem.
279: 31964-31972
[Abstract]
[Full Text]
-
Gurer, C., Cimarelli, A., Luban, J.
(2002). Specific Incorporation of Heat Shock Protein 70 Family Members into Primate Lentiviral Virions. J. Virol.
76: 4666-4670
[Abstract]
[Full Text]